STORM FAQ AND TROUBLESHOOTING

The StoRM service is a storage resource manager for generic disk based storage systems separating the data management layer from the underlying storage system

STORM: FUNCTIONAL DESCRIPTION

The StoRM service is a storage resource manager for generic disk based storage systems separating the data management layer from the underlying storage system

STORM: FUNCTIONAL DESCRIPTION

The StoRM service is a storage resource manager for generic disk based storage systems separating the data management layer from the underlying storage system

STORM: SYSTEM ADMINISTRATION GUIDE INSTALLATION AND CONFIGURATION

The StoRM service is a storage resource manager for generic disk based storage systems separating the data management layer from the underlying storage system

Third-party transfers in WLCG using HTTP

Since its earliest days, the Worldwide LHC Computational Grid (WLCG) has relied on GridFTP to transfer data between sites. The announcement that Globus is dropping support of its open source Globus Toolkit (GT), which forms the basis for several FTP client and servers, has created an opportunity to reevaluate the use of FTP. HTTP-TPC, an extension to HTTP compatible with WebDAV, has arisen as a strong contender for an alternative approach. In this paper, we describe the HTTP-TPC protocol itself, along with the current status of its support in different implementations, and the interoperability testing done within the WLCG DOMA working group's TPC activity. This protocol also provides the first real use-case for token-based authorisation for this community. We will demonstrate the benefits of such authorisation by showing how it allows HTTP-TPC to support new technologies (such as OAuth, OpenID Connect, Macaroons and SciTokens) without changing the protocol. We will also discuss the next steps for HTTP-TPC and the plans to use the protocol for WLCG transfers.Comment: 7 pages, 3 figures, to appear in the proceedings of CHEP 202

WLCG Authorisation from X.509 to Tokens

The WLCG Authorisation Working Group was formed in July 2017 with the objective to understand and meet the needs of a future-looking Authentication and Authorisation Infrastructure (AAI) for WLCG experiments. Much has changed since the early 2000s when X.509 certificates presented the most suitable choice for authorisation within the grid; progress in token based authorisation and identity federation has provided an interesting alternative with notable advantages in usability and compatibility with external (commercial) partners. The need for interoperability in this new model is paramount as infrastructures and research communities become increasingly interdependent. Over the past two years, the working group has made significant steps towards identifying a system to meet the technical needs highlighted by the community during staged requirements gathering activities. Enhancement work has been possible thanks to externally funded projects, allowing existing AAI solutions to be adapted to our needs. A cornerstone of the infrastructure is the reliance on a common token schema in line with evolving standards and best practices, allowing for maximum compatibility and easy cooperation with peer infrastructures and services. We present the work of the group and an analysis of the anticipated changes in authorisation model by moving from X.509 to token based authorisation. A concrete example of token integration in Rucio is presented.Comment: 8 pages, 3 figures, to appear in the proceedings of CHEP 201

SMN deficiency destabilizes ABCA1 expression in human fibroblasts: novel insights in pathophysiology of spinal muscular atrophy

The deficiency of survival motor neuron protein (SMN) causes spinal muscular atro- phy (SMA), a rare neuromuscular disease that affects different organs. SMN is a key player in RNA metabolism regulation. An intriguing aspect of SMN function is its relationship with plasma membrane-associated proteins. Here, we provide a first demonstration that SMN affects the ATP- binding cassette transporter A1, (ABCA1), a membrane protein critically involved in cholesterol homeostasis. In human fibroblasts, we showed that SMN associates to ABCA1 mRNA, and impacts its subcellular distribution. Consistent with the central role of ABCA1 in the efflux of free cholesterol from cells, we observed a cholesterol accumulation in SMN-depleted human fibroblasts. These results were also confirmed in SMA type I patient-derived fibroblasts. These findings not only validate the intimate connection between SMN and plasma membrane-associated proteins, but also highlight a contribution of dysregulated cholesterol efflux in SMA pathophysiology

Serum neurofilament light chain: a promising early diagnostic biomarker for hereditary transthyretin amyloidosis?

Background and purpose: Hereditary transthyretin amyloidosis (ATTRv) is a life-threatening disease caused by mutations in the gene encoding transthyretin (TTR). The recent therapeutic advances have underlined the importance of easily accessible, objective biomarkers of both disease onset and progression. Preliminary evidence suggests a potential role in this respect for neurofilament light chain (NfL). In this study, the aim was to determine serum NfL (sNfL) levels in a late-onset ATTRv population and evaluate whether it might represent a reliable biomarker of disease onset (i.e., 'conversion' from the asymptomatic status to symptomatic disease in TTR mutation carriers). Methods: In all, 111 individuals harbouring a pathogenic TTR variant (61 symptomatic ATTRv patients and 50 presymptomatic carriers) were consecutively enrolled. Fifty healthy volunteers were included as the control group. Ella™ apparatus was used to assess sNfL levels. Results: Serum NfL levels were increased in ATTRv patients compared to both presymptomatic carriers and healthy controls, whilst not differing between carriers and healthy controls. An sNfL cut-off of 37.10 pg/mL could discriminate between asymptomatic and symptomatic individuals with high diagnostic accuracy (area under the curve 0.958; p < 0.001), sensitivity (81.4%) and specificity (100%). Conclusions: Serum NfL seems to be a promising biomarker of peripheral nerve involvement in ATTRv amyloidosis and might become a reliable, objective measure to detect the transition from the presymptomatic stage to the onset of symptomatic disease. Further longitudinal studies are needed to confirm such a role and determine whether it could equally represent a biomarker of disease progression and response to therapy